Home Blog Page 77

States flock to biotech like gamblers to lottery tickets
Florida lawmakers last month approved a $310 million biotech research center proposed by Gov. Jeb Bush just three months ago. New York launched a media campaign in September to woo more biotech investors. In the past two years, New Mexico, Kentucky and Arkansas started venture-capital funds to attract and nurture biotech start-ups.

Dozens of other states might be next. A recent Brookings Institution report notes that biotech ranked as the No. 1 or No. 2 target for 83% of 113 state and local economic agencies nationwide.

The next big thing is…
According to the most recent MoneyTree Survey, a report put together by PricewaterhouseCoopers, Thomson Venture Economics and the National Venture Capital Association, which tracks venture capital investments, biotech and medical equipment firms are really the next big thing …
Although overall VC funding in the third quarter dipped 8 percent from the second quarter, investments in so-called life science firms increased 14 percent.

Pharmaceutical Makers Turn To CRM
After years of blockbuster medications that literally change the way their customers live, drugmakers are facing a period of uncertainty as the cost of developing the next big thing grows and the discovery pipeline shrinks. Many pharmaceutical companies are turning to customer-relationship-management technology as a means to squeeze revenue from existing products and prime the market for what’s to come.